Daré Bioscience announces 1-for-12 reverse stock split effective July 1, 2024 to regain Nasdaq compliance

Dare Bioscience, Inc.

1-for-12 reverse stock split effective July 1, 2024; shares reduce from ~101.1M to ~8.4M.
Purpose: regain compliance with Nasdaq $1.00 minimum bid price requirement.
Stockholder authorization obtained at June 5, 2024 annual meeting; Board set ratio at 1-for-12.
No fractional shares issued; fractional interests rounded up to next whole share after aggregation.
New CUSIP 23666P200; stock continues trading as DARE on Nasdaq.

item 3.03 item 5.03 item 7.01 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.